Baxter International Inc BAX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €21.03
- Day Range
- €21.06–21.15
- 52-Week Range
- €13.86–24.64
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 517.00M
- Market Cap
- €10.89B
- Volume/Avg
- — / 75
Key Statistics
- Price/Earnings (Normalized)
- 12.04
- Price/Sales
- 1.10
- Dividend Yield (Trailing)
- 0.17%
- Dividend Yield (Forward)
- 0.17%
- Dividend Payment Schedule
- Jan, Apr, Jul, Oct
- Total Yield
- 0.17%
Company Profile
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 37,500
- Website
- https://www.baxter.com
Competitors
Valuation
|
Metric
|
BAX
|
BDX
|
SYK
|
|---|---|---|---|
Price/Earnings (Normalized) | 12.04 | 13.70 | 19.57 |
Price/Book Value | 2.00 | 1.99 | 4.36 |
Price/Sales | 1.10 | 2.51 | 4.08 |
Price/Cash Flow | 11.43 | 13.44 | 18.68 |
Price/Earnings
BAX
BDX
SYK
Financial Strength
|
Metric
|
BAX
|
BDX
|
SYK
|
|---|---|---|---|
Quick Ratio | 1.12 | 0.36 | 1.08 |
Current Ratio | 1.95 | 0.94 | 2.16 |
Interest Coverage | −0.81 | 3.53 | — |
Quick Ratio
BAX
BDX
SYK
Profitability
|
Metric
|
BAX
|
BDX
|
SYK
|
|---|---|---|---|
Return on Assets (Normalized) | 4.99% | 4.97% | 11.44% |
Return on Equity (Normalized) | 15.42% | 10.63% | 23.97% |
Return on Invested Capital (Normalized) | 7.44% | 7.26% | 14.10% |
Return on Assets
BAX
BDX
SYK
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|D?@ZJ!GZ | LOCK|&B> | $138B | |||
| Becton Dickinson & Co
BDX
| LOCK|mwv | LOCK|K$<%x | $48B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|$wBGLhs | LOCK|GP?n | $31B | |||
| ResMed Inc
RMD
| LOCK|>J#ZBxY | LOCK|bLhy | $31B | |||
| Alcon Inc
ALC
| LOCK|@P%vFSJ | LOCK|$s>$ | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|&WBtp@Z | LOCK|QLX | $26B | |||
| Solventum Corp
SOLV
| LOCK|g>!M&x | LOCK|!X> | $15B | |||
| Baxter International Inc
BAX
| LOCK|&l | LOCK|!@v$ | $12B | |||
| The Cooper Companies Inc
COO
| LOCK|@XP&^r | LOCK|%hT^ | $11B | |||
| Repligen Corp
RGEN
| LOCK|^#NMvZcv | LOCK|s?z& | $10B |
United States